Schnoy E, Dignass A, Gaskins M, Kucharzik T, et al. Correction: From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis. Z Gastroenterol 2025;63:e668-e669.
PMID: 41825477